✦ LIBER ✦

In Vitro Pharmacology of GS-5759, a Phosphodiesterase 4 Inhibitor and 2 Agonist

Book ID: 125457256
Publisher: American Society for Pharmacology and Experimental Therapeutics
Year: 2014
Tongue: English
Weight: 59 KB
Volume: 349
Category: Article
ISSN: 0022-3565
DOI: 10.1124/jpet.114.0414hia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The In Vitro Pharmacology of GS-5759, A

The In Vitro Pharmacology of GS-5759, A Novel Bifunctional Phosphodiesterase 4 Inhibitor and Long Acting 2-Adrenoceptor Agonist

✍ Tannheimer, S. L.; Sorensen, E. A.; Cui, Z.-H.; Kim, M.; Patel, L.; Baker, W. R. 📂 Article 📅 2014 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 679 KB

Apremilast, a cAMP phosphodiesterase-4 i

Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis

✍ PH Schafer; A Parton; AK Gandhi; L Capone; M Adams; L Wu; JB Bartlett; MA Lovela 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 797 KB

Interspecies in vitro metabolism of the

Interspecies in vitro metabolism of the phosphodiesterase-4 (PDE4) inhibitor L-454,560

✍ Kevin P. Bateman; Laird Trimble; Nathalie Chauret; Jose Silva; Stephen Day; Dwig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

## Abstract L‐454,560 is a potent phospodiesterase 4 (PDE4) inhibitor which was identified as a development candidate for the treatment of asthma and chronic obstructive pulmonary disease (COPD). As part of the discovery of this compound, interspecies __in vitro__ metabolism data was generated usin

Design, synthesis and evaluation of dual

Design, synthesis and evaluation of dual pharmacology β2-adrenoceptor agonists and PDE4 inhibitors

✍ Huang, Ling; Shan, Wenjun; Zhou, Qi; Xie, Jiaxing; Lai, Kefang; Li, Xingshu 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 942 KB

The preclinical pharmacology of roflumil

The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease

✍ Armin Hatzelmann; Esteban J. Morcillo; Giuseppe Lungarella; Serge Adnot; Shahin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 663 KB

Pharmacological characterization of the

Pharmacological characterization of the neonatally sensitized rabbit model and effects of a novel phosphodiesterase (PDE) 4 inhibitor

✍ Neil Gozzard; Bernadette Hughes; Graham Warrellow; Gerry Higgs 📂 Article 📅 1998 🏛 Pharmaceutical Press 🌐 English ⚖ 102 KB